Passage Bio Inc

NASDAQ:PASG   3:59:51 PM EDT
2.38
+0.04 (+1.71%)
Products

Passage Bio Receives FDA Clearance Of Ind Application For Pbml04 For Treatment Of Metachromatic Leukodystrophy

Published: 06/08/2022 12:33 GMT
Passage Bio Inc (PASG) - Passage Bio Receives FDA Clearance of Ind Application for Pbml04 for Treatment of Metachromatic Leukodystrophy.